On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Qodo calls its secret sauce context engineering — a system-level approach to managing everything the model sees when making a decision. This includes the PR code diff, of course, but also prior ...

Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...

The 2024 DORA Accelerate State of DevOps Report provides a warning: AI use was associated with a 7% decrease in stability ...

The successful partnership between business architecture and product management can help move an AI strategy from ...

Palo Alto Networks reports Q1 with 15% revenue growth, 20 EPS beats, and a pending CyberArk merger while trading above 50x earnings. Learn why PANW stock is a hold.

Through pioneering neuromorphic computing research, Yiran Chen is developing brain-inspired hardware neurons that could lead ...